MICHAEL G MANOLIOS

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease STATEN ISLAND, NY NPI 1700913076

General Payments — all program years on this page

$509.93

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $372.27 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $372.2718

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $137.661
2024 $372.2718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078119080 Janssen Pharmaceuticals, Inc $24.14 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078119090 Janssen Pharmaceuticals, Inc $22.75 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078119178 Janssen Pharmaceuticals, Inc $15.13 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078119208 Janssen Pharmaceuticals, Inc $15.98 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078119264 Janssen Pharmaceuticals, Inc $20.29 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078119324 Janssen Pharmaceuticals, Inc $23.64 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078905545 Actelion Pharmaceuticals US, Inc. $13.76 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082369567 Tactile Systems Technology Inc $16.32 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087132986 Novartis Pharmaceuticals Corporation $26.02 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087133006 Novartis Pharmaceuticals Corporation $18.11 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087133022 Novartis Pharmaceuticals Corporation $21.83 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087133024 Novartis Pharmaceuticals Corporation $23.27 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115901031 Amgen Inc. $17.80 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148077921 Inspire Medical Systems, Inc. $33.87 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154884185 Kiniksa Pharmaceuticals International, plc $23.30 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154884207 Kiniksa Pharmaceuticals International, plc $17.63 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154884231 Kiniksa Pharmaceuticals International, plc $13.67 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154884297 Kiniksa Pharmaceuticals International, plc $24.76 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.